创美药业发布中期业绩 归母净利润2173.9万元 同比减少18.72%

Group 1 - The company reported total revenue of 2.155 billion RMB for the six months ending June 30, 2025, representing a year-on-year decrease of 8.18% [1] - The net profit attributable to the parent company was 21.739 million RMB, a decline of 18.72% compared to the previous year [1] - The basic earnings per share were 0.2013 RMB [1]